Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Anti-Retroviral Agents"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 3516
Tytuł:
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques.
Autorzy:
Lim SY; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Lee J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Osuna CE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Vikhe P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Schalk DR; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Chen E; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Fray E; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Kumar M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Schultz-Darken N; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Rakasz E; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Capuano S; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Ladd RA; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Gil HM; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Evans DT; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
Jeng EK; Altor Biosciences, Miramar, FL 33027, USA.
Seaman M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Martin M; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Van Dorp C; Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Perelson AS; Los Alamos National Laboratory, Los Alamos, NM 87545, USA.; Santa Fe Institute, Santa Fe, NM 87501, USA.
Wong HC; Altor Biosciences, Miramar, FL 33027, USA.
Siliciano JD; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Siliciano R; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.; Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Safrit JT; ImmunityBio, Culver City, CA 90232, USA.
Nixon DF; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Soon-Shiong P; ImmunityBio, Culver City, CA 90232, USA.
Nussenzweig M; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.; Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065, USA.
Whitney JB; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Department of Biology, Boston College, Chestnut Hill, MA 02467, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Mar 08; Vol. 383 (6687), pp. 1104-1111. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Retroviral Agents*/therapeutic use
Anti-Retroviral Agents*/pharmacology
Simian Acquired Immunodeficiency Syndrome*/drug therapy
Simian Acquired Immunodeficiency Syndrome*/therapy
Simian Immunodeficiency Virus*
Recombinant Fusion Proteins*/administration & dosage
Recombinant Fusion Proteins*/pharmacology
Animals ; Humans ; Broadly Neutralizing Antibodies/administration & dosage ; CD8-Positive T-Lymphocytes/virology ; Immunotherapy ; Macaca mulatta ; Viral Load ; Remission Induction ; Drug Therapy, Combination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Survival trends among people living with human immunodeficiency virus on antiretroviral treatment in two rural districts in Ghana.
Autorzy:
Sackeya E; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Tatale District Hospital, Tatale, Northern Region, Ghana.
Beru MM; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Tamale Teaching Hospital, Tamale Metropolitan, Tamale, Ghana.
Angmortey RN; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Tamale Teaching Hospital, Tamale Metropolitan, Tamale, Ghana.
Opoku DA; Allen Clinic, Family Health Services, Kumasi, Ghana.; Department of Global Health and Internal Health, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Boakye K; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Baatira M; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; St. Joseph's Midwifery Training College, Jirapa, Ghana.
Yakubu MS; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Nursing and Midwifery Training College, Nalerigu-Ghana.
Mohammed A; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Ayisi-Boateng NK; Department of Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Boateng D; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Julius Global Health, Julius Centre for Health Sciences and Primary Care, University Medical Centre, Utrecht, The Netherlands.
Nakua EK; Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Edusei AK; Department of Health Promotion, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 06; Vol. 19 (3), pp. e0290810. Date of Electronic Publication: 2024 Mar 06 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Retroviral Agents*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Humans ; Middle Aged ; Ghana/epidemiology ; Retrospective Studies ; Antiretroviral Therapy, Highly Active
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Reasons for disengagement from antiretroviral care in the era of "Treat All" in low- or middle-income countries: a systematic review.
Autorzy:
Burke RM; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.; Malawi Liverpool Wellcome Clinical Research Programme, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Rickman HM; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.; Malawi Liverpool Wellcome Clinical Research Programme, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Pinto C; Global HIV, Hepatitis and STIs Programme, World Health Organisation, Geneva, Switzerland.
Ehrenkranz P; Global Health, Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Choko A; Malawi Liverpool Wellcome Clinical Research Programme, Queen Elizabeth Central Hospital, Blantyre, Malawi.; International Public Health Department, Liverpool School of Tropical Medicine, Liverpool, UK.
Ford N; Global HIV, Hepatitis and STIs Programme, World Health Organisation, Geneva, Switzerland.; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26230.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Anti-Retroviral Agents*/therapeutic use
HIV Infections*/epidemiology
Medication Adherence*
Patient Dropouts*
Adolescent ; Female ; Humans ; Male ; Pregnancy ; Developing Countries ; Sexual and Gender Minorities
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HIV cure: The daunting scale of the problem.
Autorzy:
Siliciano JD; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Siliciano RF; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Feb 16; Vol. 383 (6684), pp. 703-705. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/virology
Virus Latency*
Anti-Retroviral Agents*/therapeutic use
Immunologic Memory*
Disease Reservoirs*/virology
Humans ; CD4-Positive T-Lymphocytes/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study.
Autorzy:
Zhao H; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Feng A; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Luo D; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Yuan T; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Lin YF; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Ling X; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
Zhong H; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
Li J; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
Li L; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China. .
Zou H; School of Public Health, Fudan University, Shanghai, China. .; School of Public Health, Southwest Medical University, Luzhou, China. .; Kirby Institute, University of New South Wales, Sydney, Australia. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Jan 29; Vol. 24 (1), pp. 138. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Anti-Retroviral Agents*/pharmacology
HIV Infections*/complications
HIV Infections*/drug therapy
Female ; Humans ; Male ; CD4 Lymphocyte Count ; Coinfection/drug therapy ; Coinfection/complications ; Hepatitis C/drug therapy ; Hepatitis C/complications ; Retrospective Studies ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Incidence and determinants of adverse events in individuals with HIV commencing Dolutegravir-based antiretroviral therapy in mainland Tanzania.
Autorzy:
Fimbo A; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania.
Mwalwisi YH; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania.
Mwamwitwa K; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania.
Matiko D; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania.
Mfinanga E; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania.
Lyimo J; World Health Organization, Dar Es Salaam, Tanzania.
Sabasaba A; Department of Epidemiology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Missago S; National Institute for Medical Research, Headquarters, Dar Es Salaam, Tanzania.
Bukundi E; Department of Epidemiology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Gotora G; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania.
Respick D; Department of Epidemiology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Nkayamba A; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania.
Masunga E; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania.
Mnkugwe RH; Department of Clinical Pharmacology, School of Biomedical Sciences, Campus College of Medicine, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Kunambi PP; Department of Clinical Pharmacology, School of Biomedical Sciences, Campus College of Medicine, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Munishi C; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Musanhu CC; World Health Organization, Dar Es Salaam, Tanzania.
Minzi OMS; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Mlugu EM; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 05; Vol. 14 (1), pp. 615. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Retroviral Agents*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Aged ; Humans ; Incidence ; Prospective Studies ; Tanzania/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Incidence and predictors of virological failure among HIV infected children and adolescents on first-line antiretroviral therapy in East Shewa hospitals, Oromia Region, Ethiopia: A retrospective follow up study.
Autorzy:
Abera NM; Department of Nursing, College of Medicine and Health Sciences, Dire Dawa University, Dire Dawa, Ethiopia.
Alemu TG; Department of Pediatrics and Child Health Nursing, School of Nursing, College of Medicine and Health Sciences and Comprehensive Specialized Hospital, University of Gondar, Gondar, Northwest Ethiopia.
Agegnehu CD; School of Nursing, College of Medicine and Health Sciences and Comprehensive specialized hospital, University of Gondar, Gondar, Ethiopia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 30; Vol. 18 (11), pp. e0289095. Date of Electronic Publication: 2023 Nov 30 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Retroviral Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Humans ; Child ; Adolescent ; Follow-Up Studies ; Retrospective Studies ; Incidence ; Ethiopia/epidemiology ; Hospitals ; Seizures/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic and antiretroviral drug resistance mutations analysis of reverse transcriptase and protease gene from Pakistani people living with HIV-1.
Autorzy:
Siddiqui D; Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.; Department of Genetics, University of Karachi, Karachi, Pakistan.
Badar U; Department of Genetics, University of Karachi, Karachi, Pakistan.
Javaid M; Bridge Consultants Foundation, Karachi, Pakistan.
Farooqui N; Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.
Shah SA; Bridge Consultants Foundation, Karachi, Pakistan.
Iftikhar A; Shaukat Khanum Memorial Hospital and Research Centre, Lahore, Pakistan.
Sultan F; Shaukat Khanum Memorial Hospital and Research Centre, Lahore, Pakistan.
Mir F; Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Furqan S; National AIDS Control Program, Ministry of Health, Islamabad, Pakistan.
Mahmood SF; Department of Medicine, Aga Khan University, Karachi, Pakistan.
Abidi SH; Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.; Department of Biomedical Sciences, Nazarbayev University School of Medicine, Astana, Kazakhstan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Aug 24; Vol. 18 (8), pp. e0290425. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Retroviral Agents*/pharmacology
Anti-Retroviral Agents*/therapeutic use
Drug Resistance, Multiple, Viral*/genetics
Genes, pol*/genetics
HIV Infections*/drug therapy
HIV Infections*/genetics
HIV-1*/drug effects
HIV-1*/genetics
Humans ; HIV Seropositivity ; Peptide Hydrolases/genetics ; RNA-Directed DNA Polymerase/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Incidence and predictors of antiretroviral treatment failure among children in public health facilities of Kolfe Keranyo Sub-City, Addis Ababa, Ethiopia: Institution-based retrospective cohort study.
Autorzy:
Misasew M; Center for Disease Control and Prevention, Addis Ababa, Ethiopia.
Menna T; St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Berhan E; St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Angassa D; MERQ Consultancy, Addis Ababa, Ethiopia.
Teshome Y; Clinton Health Access Initiative, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Aug 18; Vol. 18 (8), pp. e0266580. Date of Electronic Publication: 2023 Aug 18 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Retroviral Agents*/therapeutic use
Health Facilities*
Infant ; Humans ; Child ; Incidence ; Ethiopia/epidemiology ; Retrospective Studies ; Treatment Failure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improving the distribution of antiretroviral medicines through centralised dispensing: perspectives of HIV+ patients and nurses at a chronic dispensing unit in Ekurhuleni, Gauteng Province, South Africa.
Autorzy:
Ngende VAO; Department of Health, Ekurhuleni Chronic Dispensing Unit, Gauteng province, Johannesburg, South Africa.
Davis B; Africa Centre for HIV/AIDS Management, Faculty of Economic and Management Sciences, Stellenbosch University, Stellenbosch, South Africa.
Pokaż więcej
Źródło:
The Pan African medical journal [Pan Afr Med J] 2023 Aug 11; Vol. 45, pp. 156. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Retroviral Agents*/therapeutic use
HIV Infections*/drug therapy
Humans ; South Africa ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
Autorzy:
Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Okoye AA; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Fennessey CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Varco-Merth B; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Immonen TT; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Kose E; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Conchas A; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Pinkevych M; Infection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, Australia.
Lipkey L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Newman L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Macairan A; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Bosche M; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Berkemeier B; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Fast R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Hull M; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Silipino L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Gorelick RJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Duell D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Marenco A; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Brantley W; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Smedley J; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Axthelm M; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Davenport MP; Infection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, Australia.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Apr 09; Vol. 20 (4), pp. e1012135. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Simian Acquired Immunodeficiency Syndrome*/drug therapy
Simian Immunodeficiency Virus*/physiology
HIV Infections*/drug therapy
Animals ; Macaca mulatta ; Virus Replication ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacology ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults.
Autorzy:
Hashempour A; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Khodadad N; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ziaei R; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Rezaei B; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ghasabi F; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Falahi S; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.; Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Kenarkouhi A; Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Davarpanah MA; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. .; Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 28; Vol. 24 (1), pp. 358. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
Anti-HIV Agents*
Adult ; Humans ; Iran ; Cross-Sectional Studies ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacology ; Treatment Failure ; Viral Load ; CD4 Lymphocyte Count ; Antiretroviral Therapy, Highly Active
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
Autorzy:
Joseph SB; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC HIV Cure Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Abrahams MR; Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Moeser M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Tyers L; Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Archin NM; UNC HIV Cure Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Council OD; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC HIV Cure Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Sondgeroth A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Spielvogel E; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Emery A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Zhou S; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Doolabh D; Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Ismail SD; Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Karim SA; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu- Natal, Durban, South Africa.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Margolis DM; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC HIV Cure Center and Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Pond SK; Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.
Garrett N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu- Natal, Durban, South Africa.; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Swanstrom R; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Williamson C; Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu- Natal, Durban, South Africa.; National Health Laboratory Services of South Africa, Johannesburg, South Africa.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Feb 29; Vol. 20 (2), pp. e1011974. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*/genetics
HIV Infections*/drug therapy
Humans ; Proviruses/genetics ; Anti-Retroviral Agents/pharmacology ; Anti-Retroviral Agents/therapeutic use ; CD4-Positive T-Lymphocytes ; DNA, Viral/genetics ; DNA, Viral/metabolism ; Viral Load ; Tropism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies.
Autorzy:
Walmsley S; University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada.
Smith DE; Albion Centre, 150 Albion Street, Surry Hills NSW 2010, Sydney, Australia.
Górgolas M; Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain.
Cahn PE; Fundación Huésped, Dr. Carlos A. Gianantonio 3932, C1204 CABA, Buenos Aires, Argentina.
Lutz T; Infektiologikum, Stresemannallee 3, 60596, Frankfurt am Main, Frankfurt, Germany.
Lacombe K; Hôpital Saint-Antoine, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France.
Kumar PN; Georgetown University Medical Center, 4000 Reservoir Road, NW, Washington, DC, 20057, USA.
Wynne B; ViiV Healthcare, 406 Blackwell Street, Suite 300, Durham, NC, 27701, USA.
Grove R; GSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Bontempo G; ViiV Healthcare, 36 E Industrial Road, Branford, CT, 06405, USA.
Moodley R; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Okoli C; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Kisare M; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK. .
Jones B; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Clark A; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Ait-Khaled M; ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Pokaż więcej
Źródło:
AIDS research and therapy [AIDS Res Ther] 2024 Mar 21; Vol. 21 (1), pp. 17. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*
Anti-HIV Agents*/adverse effects
HIV Infections*/drug therapy
HIV Seropositivity*/drug therapy
Oxazines*
Piperazines*
Pyridones*
Humans ; Male ; Female ; Lamivudine/adverse effects ; Heterocyclic Compounds, 3-Ring/adverse effects ; Anti-Retroviral Agents/therapeutic use ; RNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tuberculosis Preventive Treatment Update - U.S. President's Emergency Plan for AIDS Relief, 36 Countries, 2016-2023.
Autorzy:
Ajiboye AS
O'Connor S
Smith JP
Ahmedov S
Coggin WL
Charles M
Ghosh S
Pierre P
Shah N
Teran RA
Moonan PK
Date A
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 Mar 21; Vol. 73 (11), pp. 233-238. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/epidemiology
HIV Infections*/prevention & control
HIV Infections*/drug therapy
Acquired Immunodeficiency Syndrome*/prevention & control
Tuberculosis*/epidemiology
Tuberculosis*/prevention & control
Humans ; International Cooperation ; Africa ; Anti-Retroviral Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Efficacy, safety, and tolerability of dolutegravir-based ART regimen in Durban, South Africa: a cohort study.
Autorzy:
Hurbans N; Discipline of Pharmaceutical Sciences, School of Health Sciences, College of Health Science, University of KwaZulu-Natal, Westville, Durban, 4001, South Africa. .; South African Medical Research Council, HIV and Other Infectious Diseases Research Unit, Durban, South Africa. .
Naidoo P; Discipline of Pharmaceutical Sciences, School of Health Sciences, College of Health Science, University of KwaZulu-Natal, Westville, Durban, 4001, South Africa.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 21; Vol. 24 (1), pp. 343. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV Integrase Inhibitors*/adverse effects
Oxazines*
Piperazines*
Pyridones*
Adult ; Humans ; Cohort Studies ; Retrospective Studies ; South Africa ; Cross-Sectional Studies ; Heterocyclic Compounds, 3-Ring/adverse effects ; Anti-Retroviral Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
Autorzy:
Tumwegamire A; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Fatch R; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Emenyonu NI; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Lodi S; Boston University School of Public Health, Boston, Massachusetts, United States of America.
Muyindike WR; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.; Mbarara Regional Referral Hospital, Mbarara, Uganda.
Kekibiina A; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Adong J; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Ngabirano C; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Beesiga B; Infectious Diseases Research Collaboration, Kampala, Uganda.
Marson K; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Golabi N; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Kamya M; Infectious Diseases Research Collaboration, Kampala, Uganda.
Chamie G; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Hahn JA; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 20; Vol. 19 (3), pp. e0300508. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Alcoholism*/complications
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Adult ; Female ; Cross-Sectional Studies ; Smoking/epidemiology ; Uganda/epidemiology ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Ethanol/therapeutic use ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Does HIV index testing bring patients into treatment at earlier stages of HIV disease? Results from a retrospective study in Ukraine.
Autorzy:
Secor AM; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA. .
Ihnatiuk A; International Training and Education Center for Health (I-TECH), Kyiv, Ukraine.
Shapoval A; International Training and Education Center for Health (I-TECH), Kyiv, Ukraine.
McDowell M; International Training and Education Center for Health (I-TECH), Seattle, WA, USA.
Hetman L; Public Health Center (PHC) of the Ministry of Health (MoH) of Ukraine, Kyiv, Ukraine.
Wagner AD; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.
Pintye J; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.
Beima-Sofie K; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.
Golden MR; Department of Medicine, University of Washington, Seattle, WA, USA.; HIV/STD Program, Public Health-Seattle & King County, Seattle, WA, USA.
Puttkammer N; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.; International Training and Education Center for Health (I-TECH), Seattle, WA, USA.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 18; Vol. 24 (1), pp. 328. Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Adult ; Humans ; Retrospective Studies ; Ukraine/epidemiology ; Anti-Retroviral Agents/therapeutic use ; HIV Testing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon.
Autorzy:
Nzengui-Nzengui GF; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Mourembou G; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
M'boyis-Kamdem H; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Kombila-Koumavor AC; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Ndjoyi-Mbiguino A; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 14; Vol. 24 (1), pp. 316. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
HIV Infections*/drug therapy
HIV-1*/genetics
Male ; Humans ; Female ; Reverse Transcriptase Inhibitors/therapeutic use ; HIV Protease/genetics ; Gabon ; Anti-Retroviral Agents/therapeutic use ; Protease Inhibitors/therapeutic use ; Mutation ; Drug Resistance, Viral/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.
Autorzy:
Cunha R; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Filho DBM; Postgraduate Program in Health Sciences, Universidade de Pernambuco, Recife, Brazil.
M Albuquerque MFP; Aggeu Magalhães Research Center (CPqAM), FIOCRUZ, Recife, Brazil.
Lacerda HR; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Diniz GTN; NEG-Aggeu Magalhães Research Center, Fundação Oswaldo Cruz, Recife, Brazil.
Montarroyos UR; Institute of Biological Sciences, Universidade de Pernambuco, Recife, Brazil.
Rodrigues LC; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Vilela Moura LCR; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Ximenes RAA; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 13; Vol. 19 (3), pp. e0299244. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
HIV Infections*/drug therapy
Tuberculosis*/drug therapy
Tuberculosis*/complications
Tuberculosis, Pulmonary*/drug therapy
Tuberculosis, Pulmonary*/complications
Humans ; CD4-Positive T-Lymphocytes ; CD4 Lymphocyte Count ; Anti-Retroviral Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 3516

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies